|
I agree Marlene, it makes one wonder what other drugs already exist which could help save lives and restore health for all sorts of illnesses in as-of-yet undiscovered treatment modes.
NIH's discovery that Eltrombopag can treat refractory SAA comes to mind. I wonder without NIH, if the manufacturer or anyone else would have ever discovered this.
At my treatment center (CBCI), they have been using post-BMT chemo treatment for the past couple of years (or longer?), and it seems the statistics have been very good with it for them.
__________________
Kevin, male age 45; dx SAA 02/2012 - Hgb 5.8, platelets 14, ANC 200, 1% cellularity. Received ATG 03/2012. As of 03/2015, significant improvement - Hgb 15, platelets 158, ANC fluctuates around 1000, Lymphocytes 620. Tapering cyclosporine. BMB 20-30% cellularity.
|